scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1025502654 |
P356 | DOI | 10.1038/BJC.2015.116 |
P932 | PMC publication ID | 4430713 |
P698 | PubMed publication ID | 25839987 |
P2093 | author name string | H Yoshida | |
M Yoshida | |||
S Sekine | |||
T Kinoshita | |||
Y Kanai | |||
A Ochiai | |||
R Ogawa | |||
A Maeshima | |||
P2860 | cites work | A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. | Q50645407 |
Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. | Q50990283 | ||
Phyllodes tumors of the breast segregate in two groups according to genetic criteria. | Q53567961 | ||
Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. | Q54690940 | ||
The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours | Q64019020 | ||
Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study | Q69442439 | ||
The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases | Q71018151 | ||
Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis | Q71067024 | ||
Non-operative management of breast masses diagnosed as fibroadenoma | Q71938390 | ||
Long-term risk of breast cancer in women with fibroadenoma | Q72508883 | ||
Recurrent and metastatic cystosarcoma phyllodes | Q72948474 | ||
Primary treatment of cystosarcoma phyllodes of the breast | Q73025445 | ||
Increased p53 protein expression in malignant mammary phyllodes tumors | Q74462561 | ||
Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay | Q74717587 | ||
Indicence of chronic cystic disease in so-called "normal breasts; a study based on 225 postmortem examinations | Q75795826 | ||
p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study | Q81419884 | ||
Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression | Q81419915 | ||
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors. | Q37074113 | ||
Recurrent challenges in the evaluation of fibroepithelial lesions | Q37470496 | ||
A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway | Q37721452 | ||
Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma | Q39044979 | ||
Epithelial--stromal interactions in tumors. A morphologic study of fibroepithelial tumors of the breast | Q41085895 | ||
Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours | Q46921387 | ||
Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas | Q28243075 | ||
Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor | Q33416718 | ||
Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. | Q33698048 | ||
Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas | Q34200667 | ||
MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas | Q34210977 | ||
Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. | Q34429754 | ||
Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms | Q35078803 | ||
Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors | Q35155631 | ||
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors | Q35681234 | ||
Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components | Q35809903 | ||
Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women | Q35992095 | ||
Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies | Q36029584 | ||
Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases | Q36239207 | ||
Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast | Q36922437 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1703-1708 | |
P577 | publication date | 2015-04-02 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Frequent MED12 mutations in phyllodes tumours of the breast | |
P478 | volume | 112 |
Q36907393 | Characterization of a murine xenograft model for contrast agent development in breast lesion malignancy assessment |
Q47168124 | Clinicopathology and treatment of a giant malignant phyllodes tumor of the breast: A case report and literature review |
Q52905583 | Comprehensive genomic profiling of malignant phyllodes tumors of the breast. |
Q48008521 | Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours. |
Q100526089 | Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations |
Q26785389 | Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer |
Q60956561 | Factors targeting to drive tumorigenesis? |
Q95933719 | Fibroepithelial lesions revisited: implications for diagnosis and management |
Q53267835 | Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade. |
Q41195725 | Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast |
Q41262209 | Genomic landscapes of breast fibroepithelial tumors |
Q46053202 | Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. |
Q37581351 | Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories. |
Q96955010 | Histopathologic, immunophenotypic, and proteomics characteristics of low-grade phyllodes tumor and fibroadenoma: more similarities than differences |
Q53179448 | MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast. |
Q41712515 | MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases |
Q52876304 | MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression. |
Q50120771 | MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours |
Q33915051 | Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor |
Q48508836 | Med12 regulates ovarian steroidogenesis, uterine development and maternal effects in the mammalian egg. |
Q26800203 | Mediator kinase module and human tumorigenesis |
Q93163764 | Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study |
Q35669552 | Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing |
Q39955897 | Phyllodes Tumor in a Lactating Breast |
Q42376001 | Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways |
Q28079009 | Phyllodes tumours of the breast: a consensus review |
Q92286502 | Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids |
Q93358771 | Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults |
Q47176937 | Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast |
Q36287405 | TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast |
Q64930481 | The genomic mutation spectrums of breast fibroadenomas in Chinese population by whole exome sequencing analysis. |
Q52430211 | The mediator complex in genomic and non-genomic signaling in cancer. |
Q39580452 | Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway |
Q35848142 | Uterine adenosarcomas are mesenchymal neoplasms. |
Q90446566 | Utility of Trucut Biopsy in Diagnosing Phyllodes Tumor |